TickerFactsScreenerDevelopers

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $2.02M2010: $6.85M2011: $7.51M2012: $3.38M2013: $19.11M2014: $132.51M2015: $81.21M2016: $85.37M2017: $24.84M2018: $30.13M2019: $221.80M2020: $143.58M2021: $184.43M$184.43M
2009Cash & Equivalents (USD)2021
Fiscal YearCash & EquivalentsChange YoY
2021$184.43M+28.5%
2020$143.58M-35.3%
2019$221.80M+636.1%
2018$30.13M+21.3%
2017$24.84M-70.9%
2016$85.37M+5.1%
2015$81.21M-38.7%
2014$132.51M+593.2%
2013$19.11M+466.0%
2012$3.38M-55.0%
2011$7.51M+9.6%
2010$6.85M+238.9%
2009$2.02M—